A detailed history of Pko Investment Management Joint Stock CO transactions in Dexcom Inc stock. As of the latest transaction made, Pko Investment Management Joint Stock CO holds 48,000 shares of DXCM stock, worth $3.4 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
48,000
Holding current value
$3.4 Million
% of portfolio
0.46%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Mar 13, 2025

BUY
$65.68 - $81.01 $3.15 Million - $3.89 Million
48,000 New
48,000 $3.73 Billion
Q3 2024

Mar 13, 2025

BUY
$64.0 - $116.06 $5.82 Million - $10.6 Million
91,000 Added 2275.0%
95,000 $6.37 Billion
Q2 2024

Mar 13, 2025

BUY
$110.31 - $140.45 $3.92 Million - $4.99 Million
35,500 Added 1420.0%
38,000 $4.31 Billion
Q1 2024

Mar 13, 2025

SELL
$114.22 - $140.1 $5.2 Million - $6.37 Million
-45,500 Reduced 94.79%
2,500 $348 Million
Q4 2023

Mar 13, 2025

SELL
$75.49 - $124.16 $3.32 Million - $5.46 Million
-44,000 Reduced 91.67%
4,000 $496 Million
Q3 2023

Mar 13, 2025

BUY
$86.06 - $137.93 $860,600 - $1.38 Million
10,000 Added 500.0%
12,000 $1.12 Billion
Q2 2023

Mar 13, 2025

SELL
$112.47 - $130.98 $224,940 - $261,959
-2,000 Reduced 50.0%
2,000 $257 Million
Q1 2023

Mar 13, 2025

SELL
$104.0 - $122.92 $416,000 - $491,680
-4,000 Reduced 50.0%
4,000 $465 Million
Q4 2022

Mar 13, 2025

SELL
$84.98 - $122.67 $169,960 - $245,340
-2,000 Reduced 50.0%
2,000 $226 Million
Q3 2022

Mar 13, 2025

SELL
$76.35 - $94.18 $3.36 Million - $4.14 Million
-44,000 Reduced 91.67%
4,000 $322 Million
Q2 2022

Mar 13, 2025

BUY
$67.99 - $132.89 $462,331 - $903,651
6,800 Added 566.67%
8,000 $596 Million
Q1 2022

Mar 13, 2025

SELL
$94.08 - $130.2 $4.4 Million - $6.09 Million
-46,800 Reduced 97.5%
1,200 $614 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $27.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Pko Investment Management Joint Stock CO Portfolio

Follow Pko Investment Management Joint Stock CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pko Investment Management Joint Stock CO, based on Form 13F filings with the SEC.

News

Stay updated on Pko Investment Management Joint Stock CO with notifications on news.